Tradestie Institutional Equity Comparison Engine

CAMP vs CCCC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CCCC Overall Edge

CCCC Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C4 Therapeutics, Inc. (CCCC) driven by superior Growth & Margin, Momentum & Technical while CAMP counters with relative strength in Options & Structure. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus CCCC at N/M Forward P/E and -315.9% operating margin (-24.6% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CAMP N/M vs CCCC N/M Fwd P/E
Growth & Margin Winner CCCC
Op Margin -991.8% vs -315.9% ยท YoY +138.9% vs -24.6%
Momentum & Technical Winner CCCC
1Y -3.7% vs +3.4% ยท 52W Pos 22% vs 25%
Options & Structure Winner CAMP
UNCLASSIFIED (N/A IV) vs BREAKDOWN (3rd %ile IV)
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
1M Return +25.8%
1Y Return -3.66%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
CCCC NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.56
-3.58% 1D
Market Cap $362.4M
1M Return -11.59%
1Y Return +3.44%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAMP -3.66% CCCC +3.44% Spread: +7.1 pp (CCCC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CAMP Revenue CCCC Revenue CAMP Op. Margin CCCC Op. Margin Margin Edge
FY2021 N/A $50M N/A -179.4% CCCC
FY2022 N/A $30M N/A -416.6% CCCC
FY2023 $0M $20M -14822.6% -669.8% CCCC
FY2024 $0M $40M -8142.3% -336.1% CCCC
FY2025 $0M $40M -1502.4% -320.5% CCCC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAMP (2) vs CCCC (6)
Institutional Metric CAMP CCCC Criterion Row Winner
Market Capitalization Scale $238.5M $362.4M Larger Scale CCCC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +138.9% -24.6% Higher Growth CAMP
Operating Margin (TTM) Profitability -991.8% -315.9% Higher Margin CCCC
Net Profit Margin Profitability 0.0% -282.2% Higher Margin CAMP
Return on Equity (ROE) Capital Efficiency -146.1% -47.6% Higher ROE CCCC
52-Week Range Position Momentum 22% ($3โ€“$8) 25% ($2โ€“$5) Stronger Trend CCCC
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 94% Vol 1.46ฮฒ ยท 67% Vol Lower Realized Risk CCCC
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 47.7 / 100 (HOLD) Higher Composite CCCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAMP vs CCCC Buy Guide
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CCCC BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live CCCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAMP nor CCCC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.